Oaktree Specialty Lending Corp
OCSLAnalytical Summary
Oaktree Specialty Lending Corp shows mixed fundamentals. Further due diligence is recommended before making investment decisions.
8-Year Financial Trajectory
AnnualHealth Breakdown
Dividend History
Dividend / share · sourced from SEC filingsStatement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | FY 2025 Nov 10, 2025 10-K ↗ | FY 2024 Sep 30, 2024 10-K ↗ | FY 2023 Sep 30, 2023 10-K ↗ | FY 2022 Sep 30, 2022 10-K ↗ | FY 2021 Sep 30, 2021 10-K ↗ | FY 2020 Sep 30, 2020 10-K ↗ | FY 2019 Sep 30, 2019 10-K ↗ | FY 2018 Sep 30, 2018 10-K ↗ |
|---|---|---|---|---|---|---|---|---|
| EPS Growth YoY (%) |
-45.8%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
-55.8%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
239.6%
Excellent
Excellent
Year-over-year change in earnings per share
Optimal:
> 10%
|
-89.1%
Weak
Weak
Year-over-year change in earnings per share
Optimal:
> 10%
|
— | — | — | — |
| Net Income Growth YoY (%) |
-41.4%
Weak
↓
Weak
Declining
Year-over-year change in net income |
-50.6%
Weak
↓
Weak
Declining
Year-over-year change in net income |
301.5%
Excellent
Excellent
Year-over-year change in net income |
-87.7%
Weak
Weak
Year-over-year change in net income |
— | — | — | — |
| FCF Growth YoY (%) |
1018.4%
Excellent
↑
Excellent
Improving
Year-over-year change in free cash flow |
-92.5%
Weak
Weak
Year-over-year change in free cash flow |
760.1%
Excellent
Excellent
Year-over-year change in free cash flow |
N/M | — | — | — | — |
| EPS CAGR 3Y (%) |
-6.7%
Weak
Weak
Compound annual EPS growth over 3 years |
-45.3%
Weak
Weak
Compound annual EPS growth over 3 years |
— | — | — | — | — | — |
| Metric | FY 2025 Nov 10, 2025 10-K ↗ | FY 2024 Sep 30, 2024 10-K ↗ | FY 2023 Sep 30, 2023 10-K ↗ | FY 2022 Sep 30, 2022 10-K ↗ | FY 2021 Sep 30, 2021 10-K ↗ | FY 2020 Sep 30, 2020 10-K ↗ | FY 2019 Sep 30, 2019 10-K ↗ | FY 2018 Sep 30, 2018 10-K ↗ |
|---|---|---|---|---|---|---|---|---|
| FCF / Net Income (x) |
6.73x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.33x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
1.95x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.77x
Caution
Caution
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.97x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — | — |
| Metric | FY 2025 Nov 10, 2025 10-K ↗ | FY 2024 Sep 30, 2024 10-K ↗ | FY 2023 Sep 30, 2023 10-K ↗ | FY 2022 Sep 30, 2022 10-K ↗ | FY 2021 Sep 30, 2021 10-K ↗ | FY 2020 Sep 30, 2020 10-K ↗ | FY 2019 Sep 30, 2019 10-K ↗ | FY 2018 Sep 30, 2018 10-K ↗ |
|---|---|---|---|---|---|---|---|---|
| Return on Common Equity (%) (%) |
2.3%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
3.9%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
7.7%
Caution
↓
Caution
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.3%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
18.1%
Good
Good
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
— | — | — |
| Metric | FY 2025 Nov 10, 2025 10-K ↗ | FY 2024 Sep 30, 2024 10-K ↗ | FY 2023 Sep 30, 2023 10-K ↗ | FY 2022 Sep 30, 2022 10-K ↗ | FY 2021 Sep 30, 2021 10-K ↗ | FY 2020 Sep 30, 2020 10-K ↗ | FY 2019 Sep 30, 2019 10-K ↗ | FY 2018 Sep 30, 2018 10-K ↗ |
|---|---|---|---|---|---|---|---|---|
| Debt to Equity (x) |
1.01x
Caution
→
Caution
Stable
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.10x
Caution
→
Caution
Stable
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.06x
Caution
Caution
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.04x
Caution
Caution
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
— | — | — | — |
| Net Debt (USD) | $1.41B | $1.57B | $1.46B | $1.28B | $-29.33M | — | — | — |
| Metric | FY 2025 Nov 10, 2025 10-K ↗ | FY 2024 Sep 30, 2024 10-K ↗ | FY 2023 Sep 30, 2023 10-K ↗ | FY 2022 Sep 30, 2022 10-K ↗ | FY 2021 Sep 30, 2021 10-K ↗ | FY 2020 Sep 30, 2020 10-K ↗ | FY 2019 Sep 30, 2019 10-K ↗ | FY 2018 Sep 30, 2018 10-K ↗ |
|---|---|---|---|---|---|---|---|---|
| LT Debt (USD) | $1.49B | $1.64B | $1.60B | $1.30B | — | — | — | — |
| Total Equity (USD) | $1.47B | $1.49B | $1.52B | $1.25B | $1.31B | $914.88M | — | — |
| Metric | FY 2025 Nov 10, 2025 10-K ↗ | FY 2024 Sep 30, 2024 10-K ↗ | FY 2023 Sep 30, 2023 10-K ↗ | FY 2022 Sep 30, 2022 10-K ↗ | FY 2021 Sep 30, 2021 10-K ↗ | FY 2020 Sep 30, 2020 10-K ↗ | FY 2019 Sep 30, 2019 10-K ↗ | FY 2018 Sep 30, 2018 10-K ↗ |
|---|---|---|---|---|---|---|---|---|
| Net Income, GAAP (USD) | $33.92M | $57.91M | $117.33M | $29.22M | $237.26M | — | — | — |
| Operating Cash Flow (USD) | $228.37M | $19.08M | $228.76M | $22.39M | $-230.52M | — | — | — |
Secondary lens
Benchmark Lens
Compare OCSL against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare OCSL against peers after checking the statement evidence.
Percentile Rankings
How OCSL compares to all companies
Compare OCSL with peers
Stack OCSL against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 8 years · 22 quarters